Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ranbaxy (u.k.) limited - gabapentinum - caps. - 300mg - antiepileptice alte antiepileptice

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ranbaxy (u.k.) limited - gabapentinum - caps. - 400mg - antiepileptice alte antiepileptice

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ranbaxy (u.k.) limited - gabapentinum - compr. film. - 600mg - antiepileptice alte antiepileptice

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

teva pharmaceutical works private limited company - ungaria - gabapentinum - caps. - 300mg - antiepileptice alte antiepileptice

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

teva pharmaceutical works private limited company - ungaria - gabapentinum - caps. - 400mg - antiepileptice alte antiepileptice

Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirale pentru uz sistemic - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - agenți antineoplazici - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - seruri imune și imunoglobuline, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.

Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

vbi vaccines b.v. - hepatita b antigen de suprafață - hepatita b - vaccinuri - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.

Μολδαβία - Ρουμανικά - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

medac gmbh - asparaginasum - pulbere pentru solutie injectabila - 10000 ui